Somatostatinomas are found in the major duodenal papilla (MaDP), but their diagnosis
is difficult because of their absence of symptoms and small size, and because the
tumor emerges from the submucosa [1 ]. Somatostatinomas in the minor duodenal papilla (MiDP) are extremely rare [2 ]. Most MiDP tumors are asymptomatic, while those of the MaDP more often cause jaundice
and pain [3 ].
Pancreas divisum is a common congenital anatomic variant of the pancreas and occurs
when the ventral pancreatic duct (VPD) and the dorsal pancreatic duct (DPD) do not
fuse during embryogenesis [4 ]. This disunity causes the exocrine pancreatic secretions to drain via the MiDP,
increasing the pressure within the DPD. Pancreatoduodenectomy is the option of choice
for curative treatment of neuroendocrine tumors (NETs), but the morbidity and mortality
rates are 50 % and 2 %, respectively [5 ]. As a result treatment by endoscopic papillectomy has become more attractive owing
to its lower morbidity and mortality rates. We present a rare case of somatostatinoma
in the MiDP, associated with pancreas divisum, which was treated by endoscopic papillectomy
without the insertion of a pancreatic stent even though there was pancreas divisum.
A 60-year-old woman presented with epigastric pain, and esophagogastroduodenoscopy
(EGD) showed bulging of the MiDP. A biopsy was taken; histology of this specimen revealed
a NET (grade I according to the World Health Organization [WHO] classification). Her
amylase level was 92 IU/dL; the results of chromogranin A and all other standard tests
were normal. Computed tomography (CT) scanning showed the prominent MiDP and that
the DPD was predominant, but that there was no evidence of metastases ([Fig. 1 ]) and this was confirmed by magnetic resonance imaging ([Fig. 2 ]). Endoscopic ultrasound (EUS), performed in planning for the endoscopic papillectomy,
showed a rounded hypoechoic nodule of more than 2.0 cm in size, which was restricted
to the MiDP with no invasion of the DPD, which was 35 mm in diameter, and without
communication with the VPD ([Fig. 3 ]).
Fig. 1 Computed tomography (CT) scan showing: a the dorsal pancreatic duct (DPD) emerging from the minor duodenal papilla; b below of the DPD, the ventral pancreatic duct (VPD) emerging from the major duodenal
papilla; c discontinuity of the DPD and the VPD; d the isthmus of the pancreas with the DPD predominant, while the VPD is linked to
the uncinate process.
Fig. 2 Magnetic resonance cholangiopancreatography (MRCP) image showing pancreas divisum,
with the dorsal pancreatic duct (DPD) emerging through the minor duodenal papilla
(MiDP) and the common bile duct (CBD) discharging via the major duodenal papilla (MaDP).
Fig. 3 Endoscopic ultrasound (EUS) images showing: a a hypoechoic homogeneous nodule with clear limits (1.3 × 0.8 cm) without invasion
of the dorsal pancreatic duct (DPD), which had a diameter of 35 mm; b the dominance of the DPD in the head of the pancreas; c the dominance of the DPD in the body of the pancreas; d the peridiverticular major duodenal papilla (DIV).
Endoscopic papillectomy removed the tumor en bloc and insertion of a pancreatic stent
was not required because of the dilatation of the DPD ([Fig. 4 ]). Hematochezia occurred 28 hours after the resection and was treated with clips
and injection of 1 : 10 adrenaline and glucose (25 %) ([Fig. 5 ]). The patient progressed well and was discharged 6 days after the endoscopic papillectomy.
Fig. 4 Endoscopic views showing: a the minor duodenal papilla (MiDP) with a tumor causing a slightly reddened and rough
surface; b craniocaudal capture with a polypectomy snare; c the ulcer left after en bloc tumor resection. d Photograph of the surgical specimen obtained by en bloc resection.
Fig. 5 Endoscopic view showing bleeding from the ulcer, which was treated by hemoclips and
adrenaline injection.
Imaging showing pancreas divisum (PD) with predominance of the dorsal pancreatic
duct (DPD) over the ventral pancreatic duct (VPD) and a somatostatinoma of the minor
duodenal papilla (MiDP) that was resected en bloc by endoscopic papillectomy (EP).
NET, neuroendocrine tumor; WHO, World Health Organization; MRCP, magnetic resonance
cholangiopancreatography; CT, computed tomography; CBD, common bile duct; EUS, endoscopic
ultrasound; FICE, Fuji Intelligent Chromoendoscopy.
Histology showed a grade I somatostatinoma (WHO classification) with angiolymphatic
infiltration and the following immunohistochemistry results: somatostatina (+), neuron-specific
enolase (+), synaptophysin (+), chromogranin (+), and a Ki-67/mitotic proliferation
index of < 2 %.
Endoscopy_UCTN_Code_TTT_1AO_2AZ
